About Vaishali Pharma
Vaishali Pharma is a company based in Mumbai (India) founded in 1989. The company has 15 employees as of April 04, 2024. Vaishali Pharma has completed 1 acquisition, including Kesar Pharma. Vaishali Pharma offers products and services including API, Formulations, Surgical Products, Herbal Products, and Veterinary Products. Vaishali Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
- Employees 15 as on 04 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vaishali Pharma Ltd.
-
Annual Revenue
$11.55 M (USD)14.73as on Mar 31, 2025
-
Net Profit
$95.63 K (USD)13.7as on Mar 31, 2025
-
EBITDA
-$3.75 K (USD)-102.72as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
15
as on Apr 04, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vaishali Pharma
Vaishali Pharma is a publicly listed company on the NSE with ticker symbol VAISHALI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vaishali Pharma
Vaishali Pharma offers a comprehensive portfolio of products and services, including API, Formulations, Surgical Products, Herbal Products, and Veterinary Products.
Active ingredients for therapeutic drug effects
Various dosage forms for multiple therapies
High-performance items for hospital use
Plant-based supplements for health care
Medications for affordable animal care
Vitamins and minerals for daily health
Specialized drugs for cancer diagnosis and therapy
Funding Insights of Vaishali Pharma
Detailed funding history for Vaishali Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vaishali Pharma
Vaishali Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kesar Pharma.
Investment portfolio details for Vaishali Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical finished formulations including tablets and capsules are manufactured.
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for Vaishali Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Vaishali Pharma
Detailed financials for Vaishali Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vaishali Pharma Comparisons
Peer comparison for Vaishali Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vaishali Pharma
Vaishali Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Vaishali Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vaishali Pharma
Complete news archive for Vaishali Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaishali Pharma
Vaishali Pharma was founded in 1989.
Vaishali Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anil Lakhan is the current CEO of Vaishali Pharma.
As of Apr 04, 2024, the latest employee count at Vaishali Pharma is 15.
Annual revenue of Vaishali Pharma is $11.55M as on Mar 31, 2025.
Vaishali Pharma was established in 1989 in Mumbai, India, within the pharmaceutical sector. Operations focus on producing finished formulations including tablets, capsules, syrups, semi-solids, and injectables. APIs, intermediates, and veterinary products are also manufactured. Therapeutic categories addressed include antibiotics, antiplatelet agents, antiulcer drugs, laxatives, anticold remedies, antimalarials, and additional areas.
Vaishali Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Vaishali Pharma offers API, Formulations, Surgical Products, Herbal Products, and 3 more products and services.
Yes, Vaishali Pharma is publicly traded on NSE under the ticker symbol VAISHALI.
Vaishali Pharma has made 1 acquisition, including Kesar Pharma.
The ticker symbol of Vaishali Pharma is VAISHALI on NSE.